부산대학교 도서관

Murillo, Mercedes Guerrero ; Rill-Hinarejos, Aina ; Trincado, Juan L ; Bataller, Alex ; Ortiz-Maldonado, Valentin ; Benitez-Ribas, Daniel ; Español, Marta ; González, Europa Azucena ; Martinez-Cibrian, Nuria ; Marchese, Doménica ; Martín-Martín, Lourdes ; Garcia-Sancho, Alejandro Martin ; Heyn, Holger ; Juan, Manel ; Urbano-Ispizúa, Álvaro ; Delgado, Julio ; Orfao, Alberto ; Mereu, Elisabetta ; Bueno, Clara ; Menendez, Pablo

In Experimental Hematology August 2024 137 Supplement

García‐Hernández, Violeta; Arambilet, David; Guillén, Yolanda; Lobo‐Jarne, Teresa; Maqueda, María; Gekas, Christos; González, Jessica; Iglesias, Arnau; Vega‐García, Nerea; Sentís, Inés; Trincado, Juan L; Márquez‐López, Ian; Heyn, Holger; Camós, Mireia; Espinosa, Lluis; Bigas, Anna

EMBO Molecular Medicine; 2/8/2023, Vol. 15 Issue 2, p1-17, 17p

Calama E; Almirall R+D Centre, Almirall S.A, Sant Feliu de Llobregat, Spain.; Blanco AI; Almirall R+D Centre, Almirall S.A, Sant Feliu de Llobregat, Spain.; Trincado JL; Almirall R+D Centre, Almirall S.A, Sant Feliu de Llobregat, Spain.; Nueda A; Almirall R+D Centre, Almirall S.A, Sant Feliu de Llobregat, Spain.; Gil F; Almirall R+D Centre, Almirall S.A, Sant Feliu de Llobregat, Spain.; Aniorte G; Almirall R+D Centre, Almirall S.A, Sant Feliu de Llobregat, Spain.; Godessart N; Almirall R+D Centre, Almirall S.A, Sant Feliu de Llobregat, Spain.; Gavaldà A; Almirall R+D Centre, Almirall S.A, Sant Feliu de Llobregat, Spain.

Publisher: Munksgaard Country of Publication: Denmark NLM ID: 9301549 Publication Model: Print Cited Medium: Internet ISSN: 1600-0625 (Electronic) Linking ISSN: 09066705 NLM ISO Abbreviation: Exp Dermatol Subsets: MEDLINE

Molina, Oscar; Ortega-Sabater, Carmen; Thampi, Namitha; Fernández-Fuentes, Narcís; Guerrero-Murillo, Mercedes; Martínez-Moreno, Alba; Vinyoles, Meritxell; Velasco-Hernández, Talía; Bueno, Clara; Trincado, Juan L; Granada, Isabel; Campos, Diana; Giménez, Carles; Boer, Judith M; den Boer, Monique L; Calvo, Gabriel F; Camós, Mireia; Fuster, Jose-Luis; Velasco, Pablo; Ballerini, Paola; Locatelli, Franco; Mullighan, Charles G; Spierings, Diana C J; Foijer, Floris; Pérez-García, Víctor M; Menéndez, Pablo

EMBO Molecular Medicine. 16(1):64-92

Blanco-Heredia J; IrsiCaixa, Germans Trias i Pujol University Hospital, Badalona, Spain.; Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Souza CA; IrsiCaixa, Germans Trias i Pujol University Hospital, Badalona, Spain.; Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.; Trincado JL; Centro Nacional de Análisis Genómico (CNAG), Barcelona, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Gonzalez-Cao M; Dexeus Institute of Oncology, Quironsalud Group, Barcelona, Spain.; Gonçalves-Ribeiro S; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.; Gil SR; Centro Nacional de Análisis Genómico (CNAG), Barcelona, Spain.; Pravdyvets D; Omniscope, Barcelona, Spain.; Cedeño S; IrsiCaixa, Germans Trias i Pujol University Hospital, Badalona, Spain.; Callari M; Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, UK.; Marra A; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Gazzo AM; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weigelt B; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Pareja F; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Vougiouklakis T; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Jungbluth AA; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Rosell R; Dexeus Institute of Oncology, Quironsalud Group, Barcelona, Spain.; Brander C; IrsiCaixa, Germans Trias i Pujol University Hospital, Badalona, Spain.; ICREA, Passeig de Lluís Companys, 23, Barcelona, Spain.; Universitat de Vic-Universitat Central de Catalunya, Catalunya, Spain.; Tresserra F; Dexeus Institute of Oncology, Quironsalud Group, Barcelona, Spain.; Reis-Filho JS; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Tiezzi DG; Department of Gynecology and Obstetrics - Breast Disease Division and Laboratory for Translational Data Science, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.; Advanced Research Center in Medicine (CEPAM), Union of the Colleges of the Great Lakes (UNILAGO), São José do Rio Preto, Brazil.; de la Iglesia N; IrsiCaixa, Germans Trias i Pujol University Hospital, Badalona, Spain.; Heyn H; Centro Nacional de Análisis Genómico (CNAG), Barcelona, Spain.; Omniscope, Barcelona, Spain.; De Mattos-Arruda L; IrsiCaixa, Germans Trias i Pujol University Hospital, Badalona, Spain. ldmarruda@gmail.com.; Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain. ldmarruda@gmail.com.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Guerrero-Murillo M; Rill-Hinarejos A; Trincado JL; Bataller A; Ortiz-Maldonado V; Benítez-Ribas D; Español-Rego M; González-Navarro EA; Martínez-Cibrián N; Marchese D; Martín-Martín L; García-Sancho AM; Rives S; Heyn H; Juan M; Urbano-Ispizúa Á; Delgado J; Orfao A; Mereu E; Bueno C; Menendez P

Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE; PubMed not MEDLINE

Guerrero-Murillo M; Josep Carreras Leukemia Research Institute, Barcelona, Spain; Spanish Network for Advanced Therapies, RICORS-TERAV, ISCIII, Spain; PhD programme in Biomedicine, University of Barcelona, Barcelona, Spain.; Rill-Hinarejos A; Josep Carreras Leukemia Research Institute, Barcelona, Spain; PhD programme in Biomedicine, University of Barcelona, Barcelona, Spain.; Trincado JL; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Bataller A; Department of Hematology, Hospital Clinic de Barcelona, Barcelona, Spain.; Ortiz-Maldonado V; Spanish Network for Advanced Therapies, RICORS-TERAV, ISCIII, Spain; Department of Hematology, Hospital Clinic de Barcelona, Barcelona, Spain.; Benítez-Ribas D; Department of Immunology and immunotherapy, Hospital Clinic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Español-Rego M; Department of Immunology and immunotherapy, Hospital Clinic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; González-Navarro EA; Department of Immunology and immunotherapy, Hospital Clinic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Martínez-Cibrián N; Department of Hematology, Hospital Clinic de Barcelona, Barcelona, Spain.; Marchese D; CNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Martín-Martín L; Cancer Research Centre (IBMCC, USAL-CSIC), Institute for Biomedical Research of Salamanca (IBSAL) and Department of Medicine and Cytometry Service (NUCLEUS Research Support Platform), University of Salamanca (USAL), Salamanca, Spain.; Martín García-Sancho A; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC, University of Salamanca and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain.; Rives S; Pediatric Oncology and Hematology Department, Hospital Sant Joan de Déu de Barcelona, Barcelona, Spain; Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Heyn H; CNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Juan M; Spanish Network for Advanced Therapies, RICORS-TERAV, ISCIII, Spain; Department of Immunology and immunotherapy, Hospital Clinic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Urbano-Ispizúa Á; Josep Carreras Leukemia Research Institute, Barcelona, Spain; Spanish Network for Advanced Therapies, RICORS-TERAV, ISCIII, Spain; Department of Hematology, Hospital Clinic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Delgado J; Spanish Network for Advanced Therapies, RICORS-TERAV, ISCIII, Spain; Department of Hematology, Hospital Clinic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Spanish Collaborative Cancer Network, CIBERONC, ISCIII, Spain.; Orfao A; Cancer Research Centre (IBMCC, USAL-CSIC), Institute for Biomedical Research of Salamanca (IBSAL) and Department of Medicine and Cytometry Service (NUCLEUS Research Support Platform), University of Salamanca (USAL), Salamanca, Spain; Spanish Collaborative Cancer Network, CIBERONC, ISCIII, Spain.; Mereu E; Josep Carreras Leukemia Research Institute, Barcelona, Spain. Electronic address: emereu@carrerasresearch.org.; Bueno C; Josep Carreras Leukemia Research Institute, Barcelona, Spain; Spanish Network for Advanced Therapies, RICORS-TERAV, ISCIII, Spain; Spanish Collaborative Cancer Network, CIBERONC, ISCIII, Spain. Electronic address: cbueno@carrerasresearch.org.; Menendez P; Josep Carreras Leukemia Research Institute, Barcelona, Spain; Spanish Network for Advanced Therapies, RICORS-TERAV, ISCIII, Spain; Spanish Collaborative Cancer Network, CIBERONC, ISCIII, Spain; Department of Biomedicine, University of Barcelona, Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. Electronic address: pmenendez@carrerasresearch.org.

Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

Lopez-Millan B; Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; GENYO, Centre for Genomics and Oncological Research, Pfizer/Universidad de Granada/Junta de Andalucía, Granada, Spain.; Department of Physiology, University of Granada, Granada, Spain.; Red Española de Terapias Avanzadas Network, Instituto de Salud Carlos III, Madrid, Spain.; Rubio-Gayarre A; Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; GENYO, Centre for Genomics and Oncological Research, Pfizer/Universidad de Granada/Junta de Andalucía, Granada, Spain.; Red Española de Terapias Avanzadas Network, Instituto de Salud Carlos III, Madrid, Spain.; Vinyoles M; Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Red Española de Terapias Avanzadas Network, Instituto de Salud Carlos III, Madrid, Spain.; Trincado JL; Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Fraga MF; Fundación para la Investigación Biosanitaria de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias, Instituto Universitario de Oncología de Asturias, Hospital Universitario Central de Asturias, Universidad de Oviedo, Oviedo, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III, Oviedo, Spain.; Nanomaterials and Nanotechnology Research Center, Universidad de Oviedo, Oviedo, Spain.; Fernandez-Fuentes N; Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Red Española de Terapias Avanzadas Network, Instituto de Salud Carlos III, Madrid, Spain.; Guerrero-Murillo M; Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Red Española de Terapias Avanzadas Network, Instituto de Salud Carlos III, Madrid, Spain.; Martinez A; Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Red Española de Terapias Avanzadas Network, Instituto de Salud Carlos III, Madrid, Spain.; Velasco-Hernandez T; Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Red Española de Terapias Avanzadas Network, Instituto de Salud Carlos III, Madrid, Spain.; Falgàs A; Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Red Española de Terapias Avanzadas Network, Instituto de Salud Carlos III, Madrid, Spain.; Panisello C; Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Red Española de Terapias Avanzadas Network, Instituto de Salud Carlos III, Madrid, Spain.; Valcarcel G; Epigenetic Control of Hematopoiesis Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Sardina JL; Epigenetic Control of Hematopoiesis Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; López-Martí P; 3D Chromatin Organization Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Javierre BM; 3D Chromatin Organization Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Del Valle-Pérez B; Programa de Recerca en Càncer, Institut Hospital del Mar d'Investigacions Mèdiques, Unitat Associada al Consejo Superior de Investigaciones Científicas, Departament de Medicina i Ciències de la Vida, Universitat Pompeu Fabra, Barcelona, Spain.; García de Herreros A; Programa de Recerca en Càncer, Institut Hospital del Mar d'Investigacions Mèdiques, Unitat Associada al Consejo Superior de Investigaciones Científicas, Departament de Medicina i Ciències de la Vida, Universitat Pompeu Fabra, Barcelona, Spain.; Locatelli F; Department of Pediatric Hematology-Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Bambino Gesù Children's Hospital, Rome, Italy.; Pieters R; Princess Màxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Bardini M; Tettamanti Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico San Gerardo dei Tintori, Monza, Italy.; Cazzaniga G; Tettamanti Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico San Gerardo dei Tintori, Monza, Italy.; School of Medicine and Surgery, University of Milan Bicocca, Monza, Italy.; Rodríguez-Manzaneque JC; GENYO, Centre for Genomics and Oncological Research, Pfizer/Universidad de Granada/Junta de Andalucía, Granada, Spain.; Hanewald T; Institute of Pharmaceutical Biology/Diagnostic Center of Acute Leukemia, Goethe University of Frankfurt, Biocenter, Frankfurt/Main, Germany.; Marschalek R; Institute of Pharmaceutical Biology/Diagnostic Center of Acute Leukemia, Goethe University of Frankfurt, Biocenter, Frankfurt/Main, Germany.; Milne TA; Medical Research Council, Molecular Haematology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, National Institute for Health and Care Research, Oxford Biomedical Research Center Hematology Theme, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.; Stam RW; Princess Màxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Tejedor JR; Fundación para la Investigación Biosanitaria de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias, Instituto Universitario de Oncología de Asturias, Hospital Universitario Central de Asturias, Universidad de Oviedo, Oviedo, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III, Oviedo, Spain.; Nanomaterials and Nanotechnology Research Center, Universidad de Oviedo, Oviedo, Spain.; Menendez P; Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Red Española de Terapias Avanzadas Network, Instituto de Salud Carlos III, Madrid, Spain.; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Barcelona, Spain.; Instituciò Catalana de Recerca i Estudis Avançats, Barcelona, Spain.; Bueno C; Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Red Española de Terapias Avanzadas Network, Instituto de Salud Carlos III, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Barcelona, Spain.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Ramos-Muntada M; Cell Biology, Physiology and Immunology Department, Genetics of Male Fertility Group, Universitat Autònoma de Barcelona, Spain.; Trincado JL; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Spain.; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Spain.; Red Española de Terápias Avanzadas (TERAV), ISCIII, Barcelona, Spain.; Blanco J; Cell Biology, Physiology and Immunology Department, Genetics of Male Fertility Group, Universitat Autònoma de Barcelona, Spain.; Bueno C; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Spain.; Red Española de Terápias Avanzadas (TERAV), ISCIII, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), ISCIII, Barcelona, Spain.; Rodríguez-Cortez VC; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Spain.; Red Española de Terápias Avanzadas (TERAV), ISCIII, Barcelona, Spain.; Bataller A; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Spain.; Red Española de Terápias Avanzadas (TERAV), ISCIII, Barcelona, Spain.; Hematology Department, Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Spain.; López-Millán B; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Spain.; Red Española de Terápias Avanzadas (TERAV), ISCIII, Barcelona, Spain.; Schwab C; Wolfson Childhood Cancer Research Centre, Newcastle University, UK.; Ortega M; Hematology Service, Experimental Hematology, Vall d'Hebrón Institute of Oncology (VHIO), Vall d'Hebrón Hospital Universitari, Barcelona, Spain.; Velasco P; Pediatric Oncology and Hematology Department, Vall d'Hebrón Hospital, Barcelona, Spain.; Blanco ML; Hematology Laboratory, Hospital Sant Pau, Barcelona, Spain.; Nomdedeu J; Hematology Laboratory, Hospital Sant Pau, Barcelona, Spain.; Ramírez-Orellana M; Hematology Diagnostic Laboratory, Hospital Niño Jesús, Madrid, Spain.; Minguela A; Immunology Service, Clinic University Hospital Virgen de la Arrixaca and Instituto Murciano de Investigación Biomédica (IMIB), Murcia, Spain.; Fuster JL; Pediatric Hematology and Oncology Department, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia, Spain.; Cuatrecasas E; Hematology Laboratory, Institut de Recerca Hospital Sant Joan de Déu, Barcelona, Spain.; Camós M; Hematology Laboratory, Hospital Sant Joan de Déu, University of Barcelona, Spain.; Leukemia and Other Pediatric Hemopathies, Developmental Tumor Biology Group, Institut de Recerca Hospital Sant Joan de Déu Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Ballerini P; AP-HP, Service d'Hématologie Pédiatrique, Hôpital A. Trousseau, Paris, France.; Escherich G; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg, Germany.; Boer J; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; DenBoer M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Department of Pediatric Oncology/Hematology, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands.; Hernández-Rivas JM; Departamento de Hematología, Salamanca-IBSAL, Hospital Universitario de Salamanca, Spain.; Calasanz MJ; CIMA Lab Diagnostics, Universidad de Navarra, Pamplona, Spain.; Cazzaniga G; Fondazione Tettamanti, Monza, Italy.; Harrison CJ; Wolfson Childhood Cancer Research Centre, Newcastle University, UK.; Menéndez P; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Spain.; Red Española de Terápias Avanzadas (TERAV), ISCIII, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), ISCIII, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Molina O; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Spain.; Red Española de Terápias Avanzadas (TERAV), ISCIII, Barcelona, Spain.

Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

Trincado JL; Josep Carreras Leukemia Research Institute, Badalona, Spain.; Reixachs-Solé M; Australian National University, Canberra, Australia.; EMBL Australia Partner Laboratory Network at the Australian National University, Canberra, Australia.; Pérez-Granado J; Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Medical Research Institute (IMIM), Dept. of Experimental and Health Sciences, Pompeu Fabra University (UPF), Barcelona, Spain.; Fugmann T; Philochem AG, Otelfingen, Switzerland.; Sanz F; Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Medical Research Institute (IMIM), Dept. of Experimental and Health Sciences, Pompeu Fabra University (UPF), Barcelona, Spain.; Yokota J; National Cancer Center Research Institute (NCCRI), Tokyo, Japan.; Eyras E; Australian National University, Canberra, Australia.; EMBL Australia Partner Laboratory Network at the Australian National University, Canberra, Australia.; Catalan Institution for Research and Advanced Studies, Barcelona, Spain.; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238922 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7358 (Electronic) Linking ISSN: 1553734X NLM ISO Abbreviation: PLoS Comput Biol Subsets: MEDLINE

Velasco-Hernandez T; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain.; Trincado JL; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain.; Vinyoles M; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain.; Closa A; The John Curtin School of Medical Research The Australian National University Canberra Australian Capital Territory Australia.; EMBL Australia Partner Laboratory Network at the Australian National University Canberra Australian Capital Territory Australia.; Martínez-Moreno A; Josep Carreras Leukemia Research Institute Barcelona Spain.; Gutiérrez-Agüera F; Josep Carreras Leukemia Research Institute Barcelona Spain.; Molina O; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain.; Rodríguez-Cortez VC; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain.; Ximeno-Parpal P; Josep Carreras Leukemia Research Institute Barcelona Spain.; Fernández-Fuentes N; Josep Carreras Leukemia Research Institute Barcelona Spain.; Petazzi P; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain.; Beneyto-Calabuig S; Centre for Genomic Regulation (CRG) The Barcelona Institute of Science and Technology Barcelona Spain.; Universitat Pompeu Fabra (UPF) Barcelona Spain.; Velten L; Centre for Genomic Regulation (CRG) The Barcelona Institute of Science and Technology Barcelona Spain.; Universitat Pompeu Fabra (UPF) Barcelona Spain.; Romecin P; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain.; Casquero R; Josep Carreras Leukemia Research Institute Barcelona Spain.; Abollo-Jiménez F; Bioinformatics Unit Maimonides Biomedical Research Institute of Córdoba (IMIBIC) Córdoba Spain.; de la Guardia RD; Josep Carreras Leukemia Research Institute Barcelona Spain.; GENYO, Center for Genomics and Oncological Research Pfizer/Universidad de Granada/Junta de Andalucía Granada Spain.; Lorden P; CNAG-CRG, Centre for Genomic Regulation (CRG) Barcelona Institute of Science and Technology (BIST) Barcelona Spain.; Bataller A; Department of Hematology Hospital Clínic de Barcelona Barcelona Spain.; Lapillonne H; Centre de Recherce Saint-Antoine Armand-Trousseau Childrens Hospital Paris France.; Stam RW; Princess Maxima Center for Pediatric Oncology Utrecht The Netherlands.; Vives S; Josep Carreras Leukemia Research Institute Barcelona Spain.; Hematology Department ICO-Hospital Germans Trias i Pujol Barcelona Spain.; Torrebadell M; Hematology Laboratory Hospital Sant Joan de Déu Barcelona Spain.; Leukemia and Other Pediatric Hemopathies. Developmental Tumors Biology Group. Institut de Recerca Hospital Sant Joan de Déu Barcelona Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) ISCIII Madrid Spain.; Fuster JL; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain.; Sección de Oncohematología Pediátrica Hospital Clínico Universitario Virgen de la Arrixaca and Instituto Murciano de Investigación Biosanitaria (IMIB) Murcia Spain.; Bueno C; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain.; CIBER-ONC Barcelona Spain.; Sarry JE; Centre de Recherches en Cancérologie de Toulouse Université de Toulouse Inserm U1037, CNRS U5077 Toulouse France.; LabEx Toucan Toulouse France.; Équipe Labellisée Ligue Nationale Contre le Cancer Toulouse France.; Eyras E; The John Curtin School of Medical Research The Australian National University Canberra Australian Capital Territory Australia.; EMBL Australia Partner Laboratory Network at the Australian National University Canberra Australian Capital Territory Australia.; Hospital del Mar Medical Research Institute (IMIM) Barcelona Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA) Barcelona Spain.; Heyn H; CNAG-CRG, Centre for Genomic Regulation (CRG) Barcelona Institute of Science and Technology (BIST) Barcelona Spain.; Menéndez P; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain.; CIBER-ONC Barcelona Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA) Barcelona Spain.; Department of Biomedicine, School of Medicine University of Barcelona Barcelona Spain.

Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

Rubio-Perez C; Vall d Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, 08035, Barcelona, Spain.; Planas-Rigol E; Vall d Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, 08035, Barcelona, Spain.; Trincado JL; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Bonfill-Teixidor E; Vall d Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, 08035, Barcelona, Spain.; Arias A; Vall d Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, 08035, Barcelona, Spain.; Marchese D; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Moutinho C; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Serna G; Vall d Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, 08035, Barcelona, Spain.; Pedrosa L; Hospital Clinic, University of Barcelona and Institut d'Investigacio Biomedica August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Iurlaro R; Vall d Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, 08035, Barcelona, Spain.; Martínez-Ricarte F; Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron University Hospital, 08035, Barcelona, Spain.; Universitat Autònoma de Barcelona (UAB), 08193, Cerdanyola del Vallès, Spain.; Escudero L; Vall d Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, 08035, Barcelona, Spain.; Cordero E; Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron University Hospital, 08035, Barcelona, Spain.; Universitat Autònoma de Barcelona (UAB), 08193, Cerdanyola del Vallès, Spain.; Cicuendez M; Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron University Hospital, 08035, Barcelona, Spain.; Universitat Autònoma de Barcelona (UAB), 08193, Cerdanyola del Vallès, Spain.; Ruiz S; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Parra G; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Nuciforo P; Vall d Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, 08035, Barcelona, Spain.; Gonzalez J; Hospital Clinic, University of Barcelona and Institut d'Investigacio Biomedica August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Pineda E; Hospital Clinic, University of Barcelona and Institut d'Investigacio Biomedica August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Sahuquillo J; Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron University Hospital, 08035, Barcelona, Spain.; Universitat Autònoma de Barcelona (UAB), 08193, Cerdanyola del Vallès, Spain.; Tabernero J; Vall d Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, 08035, Barcelona, Spain.; Universitat Autònoma de Barcelona (UAB), 08193, Cerdanyola del Vallès, Spain.; CIBERONC, Barcelona, Spain.; Heyn H; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. holger.heyn@cnag.crg.eu.; Universitat Pompeu Fabra (UPF), Barcelona, Spain. holger.heyn@cnag.crg.eu.; Seoane J; Vall d Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, 08035, Barcelona, Spain. jseoane@vhio.net.; Universitat Autònoma de Barcelona (UAB), 08193, Cerdanyola del Vallès, Spain. jseoane@vhio.net.; CIBERONC, Barcelona, Spain. jseoane@vhio.net.; Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010, Barcelona, Spain. jseoane@vhio.net.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Franco-Valls H; Programa de Recerca en Càncer, Hospital del Mar Research Institute (IMIM), Dr. Aiguader, 88, 08003, Barcelona, Spain.; Tusquets-Uxó E; Programa de Recerca en Càncer, Hospital del Mar Research Institute (IMIM), Dr. Aiguader, 88, 08003, Barcelona, Spain.; Institute for Research in Biomedicine, Barcelona, Spain.; Sala L; Programa de Recerca en Càncer, Hospital del Mar Research Institute (IMIM), Dr. Aiguader, 88, 08003, Barcelona, Spain.; National Institutes of Health: Intramural Research Program, Bethesda, MD, USA.; Val M; Programa de Recerca en Càncer, Hospital del Mar Research Institute (IMIM), Dr. Aiguader, 88, 08003, Barcelona, Spain.; Vall Hebron Institute of Research, Barcelona, Spain.; Peña R; Programa de Recerca en Càncer, Hospital del Mar Research Institute (IMIM), Dr. Aiguader, 88, 08003, Barcelona, Spain.; Iaconcig A; International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.; Villarino Á; Unitat Biofísica i Bioenginyeria, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.; CIBER de Enfermedades Respiratorias, Madrid, Spain.; Jiménez-Arriola M; Programa de Recerca en Càncer, Hospital del Mar Research Institute (IMIM), Dr. Aiguader, 88, 08003, Barcelona, Spain.; Massó P; Programa de Recerca en Càncer, Hospital del Mar Research Institute (IMIM), Dr. Aiguader, 88, 08003, Barcelona, Spain.; Trincado JL; Research Program of Biomedical Informatics, Hospital del Mar Research Institute (IMIM), Barcelona, Spain.; Josep Carreras Leukaemia Research Institute, Barcelona, Spain.; Eyras E; Research Program of Biomedical Informatics, Hospital del Mar Research Institute (IMIM), Barcelona, Spain.; John Curtin School of Medical Research, Australian National University, Canberra, Australia.; Muro AF; International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.; Otero J; Unitat Biofísica i Bioenginyeria, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.; CIBER de Enfermedades Respiratorias, Madrid, Spain.; García de Herreros A; Programa de Recerca en Càncer, Hospital del Mar Research Institute (IMIM), Dr. Aiguader, 88, 08003, Barcelona, Spain.; Departament de Medicina i Ciències de la Vida, Universitat Pompeu Fabra, Barcelona, Spain.; Baulida J; Programa de Recerca en Càncer, Hospital del Mar Research Institute (IMIM), Dr. Aiguader, 88, 08003, Barcelona, Spain. jbaulida@imim.es.

Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE

Bueno C; Josep Carreras Leukemia Research Institute, Campus Clinic, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Oncología (CIBER-ONC) and.; Red Española de Terapias Avanzadas (TERAV), Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS RD21/0017/0029), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Barrera S; Centro de Investigación Biomédica en Red en Oncología (CIBER-ONC) and.; Cancer Research Center (IBMCC-CSIC/USAL-IBSAL), Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Salamanca, Spain.; Bataller A; Josep Carreras Leukemia Research Institute, Campus Clinic, Barcelona, Spain.; Department of Clinical Hematology, Hospital Clinic of Barcelona, Barcelona, Spain.; Ortiz-Maldonado V; Department of Clinical Hematology, Hospital Clinic of Barcelona, Barcelona, Spain.; Elliot N; Department of Paediatrics, Children's Hospital, John Radcliffe Hospital.; O'Byrne S; Department of Paediatrics, Children's Hospital, John Radcliffe Hospital.; Wang G; MRC (Medical Research Council) Molecular Haematology Unit, and.; Centre for Computational Biology, MRC Weatherall Institute of Molecular Medicine (WIMM), University of Oxford, Oxford, United Kingdom.; Rovira M; Centre for Computational Biology, MRC Weatherall Institute of Molecular Medicine (WIMM), University of Oxford, Oxford, United Kingdom.; Gutierrez-Agüera F; Josep Carreras Leukemia Research Institute, Campus Clinic, Barcelona, Spain.; Trincado JL; Josep Carreras Leukemia Research Institute, Campus Clinic, Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV), Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS RD21/0017/0029), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; González-González M; Centro de Investigación Biomédica en Red en Oncología (CIBER-ONC) and.; Cancer Research Center (IBMCC-CSIC/USAL-IBSAL), Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Salamanca, Spain.; Morgades M; Clinical Hematology Department, ICO-Hospital Germans Trias i Pujol, Badalona, Spain.; Sorigué M; Clinical Hematology Department, ICO-Hospital Germans Trias i Pujol, Badalona, Spain.; Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona (UAB), Badalona, Spain.; Bárcena P; Centro de Investigación Biomédica en Red en Oncología (CIBER-ONC) and.; Cancer Research Center (IBMCC-CSIC/USAL-IBSAL), Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Salamanca, Spain.; Zanetti SR; Josep Carreras Leukemia Research Institute, Campus Clinic, Barcelona, Spain.; Torrebadell M; Haematology Laboratory, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain.; Developmental Tumor Biology Group, Leukemia and Other Pediatric Hemopathies, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Madrid, Spain.; Vega-Garcia N; Haematology Laboratory, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain.; Developmental Tumor Biology Group, Leukemia and Other Pediatric Hemopathies, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Rives S; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Madrid, Spain.; Department of Clinical Hematology, Hospital Sant Joan de Déu, Barcelona, Spain.; Mallo M; Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona (UAB), Badalona, Spain.; Sole F; Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona (UAB), Badalona, Spain.; Mead AJ; Department of Paediatrics, Children's Hospital, John Radcliffe Hospital.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Madrid, Spain.; Roberts I; Department of Paediatrics, Children's Hospital, John Radcliffe Hospital.; MRC (Medical Research Council) Molecular Haematology Unit, and.; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, United Kingdom.; Thongjuea S; Department of Paediatrics, Children's Hospital, John Radcliffe Hospital.; MRC (Medical Research Council) Molecular Haematology Unit, and.; Department of Clinical Hematology, Hospital Sant Joan de Déu, Barcelona, Spain.; Psaila B; Department of Paediatrics, Children's Hospital, John Radcliffe Hospital.; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, United Kingdom.; Juan M; Red Española de Terapias Avanzadas (TERAV), Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS RD21/0017/0029), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Immunology Department, Hospital Clinic of Barcelona, Barcelona, Spain.; Delgado J; Centro de Investigación Biomédica en Red en Oncología (CIBER-ONC) and.; Red Española de Terapias Avanzadas (TERAV), Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS RD21/0017/0029), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Department of Clinical Hematology, Hospital Clinic of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Urbano-Ispizúa A; Josep Carreras Leukemia Research Institute, Campus Clinic, Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV), Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS RD21/0017/0029), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Department of Clinical Hematology, Hospital Clinic of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Ribera JM; Red Española de Terapias Avanzadas (TERAV), Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS RD21/0017/0029), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Clinical Hematology Department, ICO-Hospital Germans Trias i Pujol, Badalona, Spain.; Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona (UAB), Badalona, Spain.; Orfao A; Centro de Investigación Biomédica en Red en Oncología (CIBER-ONC) and.; Cancer Research Center (IBMCC-CSIC/USAL-IBSAL), Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Salamanca, Spain.; Roy A; Department of Paediatrics, Children's Hospital, John Radcliffe Hospital.; MRC (Medical Research Council) Molecular Haematology Unit, and.; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, United Kingdom.; Menendez P; Josep Carreras Leukemia Research Institute, Campus Clinic, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Oncología (CIBER-ONC) and.; Red Española de Terapias Avanzadas (TERAV), Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS RD21/0017/0029), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain; and.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Trincado JL; Pompeu Fabra University, E08003, Barcelona, Spain.; Entizne JC; University of Dundee, Invergowrie, Dundee, DD2 5DA, UK.; Hysenaj G; Institute of Genetic Medicine, Newcastle University, Central Parkway, Newcastle, NE1 3BZ, UK.; Singh B; Pompeu Fabra University, E08003, Barcelona, Spain.; Skalic M; Pompeu Fabra University, E08003, Barcelona, Spain.; Elliott DJ; Institute of Genetic Medicine, Newcastle University, Central Parkway, Newcastle, NE1 3BZ, UK.; Eyras E; Pompeu Fabra University, E08003, Barcelona, Spain. eduardo.eyras@upf.edu.; Catalan Institution for Research and Advanced Studies, E08010, Barcelona, Spain. eduardo.eyras@upf.edu.

Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100960660 Publication Model: Electronic Cited Medium: Internet ISSN: 1474-760X (Electronic) Linking ISSN: 14747596 NLM ISO Abbreviation: Genome Biol Subsets: MEDLINE

Nieto P; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.; Elosua-Bayes M; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.; Trincado JL; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.; Marchese D; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.; Massoni-Badosa R; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.; Salvany M; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, 08028 Barcelona, Spain.; Henriques A; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, 08028 Barcelona, Spain.; Nieto J; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.; Aguilar-Fernández S; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.; Mereu E; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.; Moutinho C; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.; Ruiz S; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.; Lorden P; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.; Chin VT; Garvan-Weizmann Centre for Cellular Genomics, Garvan Institute of Medical Research, Darlinghurst NSW 2010, Sydney, Australia.; St. Vincent's Hospital Clinical School, University of New South Wales, Sydney, Australia, and St. Vincent's Hospital Sydney, Darlinghurst NSW 2010, Australia.; St. Vincent's Hospital Sydney, Darlinghurst NSW 2010, Australia.; Kaczorowski D; Garvan-Weizmann Centre for Cellular Genomics, Garvan Institute of Medical Research, Darlinghurst NSW 2010, Sydney, Australia.; Chan CL; Garvan-Weizmann Centre for Cellular Genomics, Garvan Institute of Medical Research, Darlinghurst NSW 2010, Sydney, Australia.; Gallagher R; St. Vincent's Hospital Sydney, Darlinghurst NSW 2010, Australia.; University of Notre Dame, Chippendale NSW 2007, Sydney, Australia.; Chou A; Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards NSW 2065, Australia.; NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital, Sydney NSW 2065, Australia.; University of Sydney, Sydney NSW 2006, Australia.; Planas-Rigol E; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, 08035 Barcelona, Spain.; Rubio-Perez C; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, 08035 Barcelona, Spain.; Gut I; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.; Piulats JM; Medical Oncology Department, Institut Català d'Oncologia - ICO; Clinical Research in Solid Tumors Group - CREST, Bellvitge Biomedical Research Institute IDIBELL-OncoBell; CIBERONC; 08908 L'Hospitalet de Llobregat, Barcelona, Spain.; Seoane J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, 08035 Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain.; Universitat Autònoma de Barcelona (UAB), 08193 Barcelona, Spain.; CIBERONC, 08908 Barcelona, Spain.; Powell JE; Garvan-Weizmann Centre for Cellular Genomics, Garvan Institute of Medical Research, Darlinghurst NSW 2010, Sydney, Australia.; UNSW Cellular Genomics Futures Institute, University of New South Wales, Sydney NSW 2052, Australia.; Batlle E; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, 08028 Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain.; CIBERONC, 08908 Barcelona, Spain.; Heyn H; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.; Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain.

Publisher: Cold Spring Harbor Laboratory Press Country of Publication: United States NLM ID: 9518021 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-5469 (Electronic) Linking ISSN: 10889051 NLM ISO Abbreviation: Genome Res Subsets: MEDLINE

de Barrios O; Lymphocyte Development and Disease Group, Josep Carreras Leukaemia Research Institute (IJC), Ctra. de Can Ruti, Camí de les Escoles, s/n, 08916, Badalona, Barcelona, Spain.; Cellular Differentiation Group, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Barcelona, Spain.; Galaras A; Biomedical Sciences Research Center 'Alexander Fleming', 16672, Vari, Greece.; Department of Biochemistry and Biotechnology, University of Thessaly, Larissa, Greece.; Trincado JL; Josep Carreras Leukaemia Research Institute, School of Medicine, University of Barcelona, 08036, Barcelona, Spain.; Azagra A; Lymphocyte Development and Disease Group, Josep Carreras Leukaemia Research Institute (IJC), Ctra. de Can Ruti, Camí de les Escoles, s/n, 08916, Badalona, Barcelona, Spain.; Cellular Differentiation Group, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Barcelona, Spain.; Collazo O; Lymphocyte Development and Disease Group, Josep Carreras Leukaemia Research Institute (IJC), Ctra. de Can Ruti, Camí de les Escoles, s/n, 08916, Badalona, Barcelona, Spain.; Cellular Differentiation Group, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Barcelona, Spain.; Meler A; Lymphocyte Development and Disease Group, Josep Carreras Leukaemia Research Institute (IJC), Ctra. de Can Ruti, Camí de les Escoles, s/n, 08916, Badalona, Barcelona, Spain.; Cellular Differentiation Group, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Barcelona, Spain.; Agraz-Doblas A; Josep Carreras Leukaemia Research Institute, School of Medicine, University of Barcelona, 08036, Barcelona, Spain.; Instituto de Biomedicina y Biotecnología de Cantabria, Universidad de Cantabria-CSIC, Santander, Spain.; Bueno C; Josep Carreras Leukaemia Research Institute, School of Medicine, University of Barcelona, 08036, Barcelona, Spain.; Ballerini P; Department of Pediatric Hematology, A. Trousseau Hospital, Paris, France.; Cazzaniga G; Centro Ricerca Tettamanti, Department of Pediatrics, University of Milano-Bicocca, Fondazione MBBM, Monza, Italy.; Stam RW; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Varela I; Instituto de Biomedicina y Biotecnología de Cantabria, Universidad de Cantabria-CSIC, Santander, Spain.; De Lorenzo P; Centro Ricerca Tettamanti, Department of Pediatrics, University of Milano-Bicocca, Fondazione MBBM, Monza, Italy.; Interfant Trial Data Center, University of Milano-Bicocca, Monza, Italy.; Valsecchi MG; Interfant Trial Data Center, University of Milano-Bicocca, Monza, Italy.; Hatzis P; Biomedical Sciences Research Center 'Alexander Fleming', 16672, Vari, Greece.; Menéndez P; Josep Carreras Leukaemia Research Institute, School of Medicine, University of Barcelona, 08036, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; CIBER-ONC-ISCIII, Barcelona, Spain.; Parra M; Lymphocyte Development and Disease Group, Josep Carreras Leukaemia Research Institute (IJC), Ctra. de Can Ruti, Camí de les Escoles, s/n, 08916, Badalona, Barcelona, Spain. mparra@carrerasresearch.org.; Cellular Differentiation Group, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Barcelona, Spain. mparra@carrerasresearch.org.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Molina O; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain.; Vinyoles M; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain.; Granada I; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain.; Hematology Laboratory, Germans Trias i Pujol University Hospital-Catalan Institute of Oncology, Badalona, Spain.; Roca-Ho H; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain.; Gutierrez-Agüera F; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain.; Valledor L; Department of Physical and Analytical Chemistry, University of Oviedo, Asturias, Spain.; López-López CM; Department of Physical and Analytical Chemistry, University of Oviedo, Asturias, Spain.; Rodríguez-González P; Department of Physical and Analytical Chemistry, University of Oviedo, Asturias, Spain.; Trincado JL; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain.; Menéndez ST; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias, Oviedo, Spain.; CIBER-ONC, ISCIII, Madrid, Spain.; Pal D; Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.; Department of Applied Sciences, Northumbria University, Newcastle upon Tyne, United Kingdom.; Ballerini P; Pediatric Hematology, A. Trousseau Hospital, Paris, France.; den Boer ML; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Plensa I; Hematology Laboratory, Institut Recerca Hospital Sant Joan de Déu, Barcelona, Spain.; Mar Perez-Iribarne M; Hematology Laboratory, Institut Recerca Hospital Sant Joan de Déu, Barcelona, Spain.; Rodríguez-Perales S; Molecular Cytogenetics Group, Centro Nacional de Investigaciones Oncológicas, Madrid, Spain.; Calasanz MJ; CIMA Laboratory Diagnostics, Universidad de Navarra, Pamplona, Spain.; Ramírez-Orellana M; Hematology Diagnostic Laboratory, Hospital Niño Jesús, Madrid, Spain.; Rodríguez R; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias, Oviedo, Spain.; CIBER-ONC, ISCIII, Madrid, Spain.; Camós M; Hematology Laboratory, Institut Recerca Hospital Sant Joan de Déu, Barcelona, Spain.; Leukemia and Other Pediatric Hemopathies, Developmental Tumors Biology Group, Institut de Recerca Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Barcelona, Spain.; Calvo M; Scientific and Technological Centers, Universitat de Barcelona (CCiTUB) Campus Clínic, Barcelona, Spain; and.; Bueno C; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain.; Menéndez P; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Singh B; Department of Experimental and Health Sciences, Pompeu Fabra University (UPF), Barcelona, Spain.; Trincado JL; Department of Experimental and Health Sciences, Pompeu Fabra University (UPF), Barcelona, Spain.; Tatlow PJ; Department of Biology, Brigham Young University, Provo, Utah.; Piccolo SR; Department of Biology, Brigham Young University, Provo, Utah.; Department of Biomedical Informatics, University of Utah, Salt Lake City, Utah.; Eyras E; Department of Experimental and Health Sciences, Pompeu Fabra University (UPF), Barcelona, Spain. eduardo.eyras@upf.edu.; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE

Trincado JL; Universitat Pompeu Fabra (UPF), Dr. Aiguader 88, E08003, Barcelona, Spain.; Sebestyén E; IFOM, the FIRC Institute of Molecular Oncology, Via Adamello 16, 20139, Milan, Italy.; Pagés A; Universitat Pompeu Fabra (UPF), Dr. Aiguader 88, E08003, Barcelona, Spain.; Eyras E; Universitat Pompeu Fabra (UPF), Dr. Aiguader 88, E08003, Barcelona, Spain. eduardo.eyras@upf.edu.; Catalan Institution for Research and Advanced Studies (ICREA), Passeig Lluís Companys 23, E08010, Barcelona, Spain. eduardo.eyras@upf.edu.

Publisher: BioMed Central Country of Publication: England NLM ID: 101475844 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-994X (Electronic) Linking ISSN: 1756994X NLM ISO Abbreviation: Genome Med Subsets: MEDLINE